Login / Signup

Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy.

A CoppolaA D'AusilioA AielloS AmoresanoM ToumiP MathewAnnarita Tagliaferrinull null
Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2017)
Late prophylaxis vs. on-demand therapy results in a cost-effective approach with ICERs falling below the threshold considered acceptable in Italy.
Keyphrases
  • early onset
  • stem cells
  • combination therapy
  • mesenchymal stem cells
  • replacement therapy